These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37992788)

  • 1. Social isolation, loneliness, and inflammation: A multi-cohort investigation in early and mid-adulthood.
    Matthews T; Rasmussen LJH; Ambler A; Danese A; Eugen-Olsen J; Fancourt D; Fisher HL; Iversen KK; Schultz M; Sugden K; Williams B; Caspi A; Moffitt TE
    Brain Behav Immun; 2024 Jan; 115():727-736. PubMed ID: 37992788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking stressful life events and chronic inflammation using suPAR (soluble urokinase plasminogen activator receptor).
    Bourassa KJ; Rasmussen LJH; Danese A; Eugen-Olsen J; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE; Caspi A
    Brain Behav Immun; 2021 Oct; 97():79-88. PubMed ID: 34224821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal associations between adolescents' individualised risk for depression and inflammation in a UK cohort study.
    Latham RM; Kieling C; Arseneault L; Kohrt BA; Moffitt TE; Rasmussen LJH; Rocha TB; Mondelli V; Fisher HL
    Brain Behav Immun; 2022 Mar; 101():78-83. PubMed ID: 34990745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.
    Rasmussen LJH; Moffitt TE; Eugen-Olsen J; Belsky DW; Danese A; Harrington H; Houts RM; Poulton R; Sugden K; Williams B; Caspi A
    J Child Psychol Psychiatry; 2019 Feb; 60(2):199-208. PubMed ID: 29741788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble urokinase Plasminogen Activator Receptor (suPAR) mediates the effect of a lower education level on adverse outcomes in patients with coronary artery disease.
    Füller D; Liu C; Ko YA; Alkhoder AA; Desai SR; Almuwaqqat Z; Patel SA; Ejaz K; Kauser T; Martini MA; Alvi Z; Mehta PK; Sperling LS; Quyyumi AA
    Eur J Prev Cardiol; 2024 Mar; 31(5):521-528. PubMed ID: 37788634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Adverse Experiences and Exposure to Violence in Childhood and Adolescence With Inflammatory Burden in Young People.
    Rasmussen LJH; Moffitt TE; Arseneault L; Danese A; Eugen-Olsen J; Fisher HL; Harrington H; Houts R; Matthews T; Sugden K; Williams B; Caspi A
    JAMA Pediatr; 2020 Jan; 174(1):38-47. PubMed ID: 31682707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging.
    Rasmussen LJH; Caspi A; Ambler A; Danese A; Elliott M; Eugen-Olsen J; Hariri AR; Harrington H; Houts R; Poulton R; Ramrakha S; Sugden K; Williams B; Moffitt TE
    J Gerontol A Biol Sci Med Sci; 2021 Jan; 76(2):318-327. PubMed ID: 32766674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
    Rasmussen LJH; Petersen JEV; Eugen-Olsen J
    Front Immunol; 2021; 12():780641. PubMed ID: 34925360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia.
    Toldi G; Bíró E; Szalay B; Stenczer B; Molvarec A; Rigó J; Vásárhelyi B; Bekõ G
    Clin Chem Lab Med; 2011 Nov; 49(11):1873-6. PubMed ID: 21722073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
    Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
    Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 23, hepatocyte growth factor, interleukin-6, high-sensitivity C-reactive protein and soluble urokinase plasminogen activator receptor. Inflammation markers in chronic haemodialysis patients?
    Almroth G; Lönn J; Uhlin F; Nayeri F; Brudin L; Andersson B; Hahn-Zoric M
    Scand J Immunol; 2013 Sep; 78(3):285-90. PubMed ID: 23721058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: A nested case-control study.
    Mongan D; Raj Susai S; Föcking M; Byrne JF; Zammit S; Cannon M; Cotter DR
    Brain Behav Immun; 2023 Jul; 111():90-100. PubMed ID: 37004760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
    Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
    Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
    Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
    Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study.
    Kostopoulou E; Kalavrizioti D; Davoulou P; Sinopidis X; Papachristou E; Goumenos DS; Dimitriou G; Spiliotis BE; Papasotiriou M
    Eur J Pediatr; 2024 May; 183(5):2383-2389. PubMed ID: 38448612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-protein diet during hospitalization is associated with an accelerated decrease in soluble urokinase plasminogen activator receptor levels in acutely ill elderly medical patients with SIRS.
    Tavenier J; Haupt TH; Andersen AL; Buhl SF; Langkilde A; Andersen JR; Jensen JB; Pedersen MM; Petersen J; Andersen O
    Nutr Res; 2017 May; 41():56-64. PubMed ID: 28477944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
    Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
    J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble urokinase plasminogen activator receptor as a prognostic marker of all-cause and cardiovascular mortality in a black population.
    Botha S; Fourie CMT; Schutte R; Eugen-Olsen J; Pretorius R; Schutte AE
    Int J Cardiol; 2015 Apr; 184():631-636. PubMed ID: 25771228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Urokinase Receptor Levels Are Not Affected by the Systemic Inflammatory Response to Anesthesia and Operative Trauma.
    Laou E; Papagiannakis N; Tsiaka A; Tsapournioti S; Chatzikallinikidis K; Mantzaflaras G; Karadontas I; Eugen-Olsen J; Chalkias A
    Eur Surg Res; 2022; 63(4):249-256. PubMed ID: 35385841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.